table of content
1 Study Coverage
1.1 Parenteral Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Parenteral Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 LVP Drug
1.2.3 SVP Drug
1.3 Market by Application
1.3.1 Global Parenteral Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Medical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Parenteral Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Parenteral Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Parenteral Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Parenteral Drugs Sales by Region
2.4.1 Global Parenteral Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Parenteral Drugs by Region (2023-2028)
2.5 Global Parenteral Drugs Revenue by Region
2.5.1 Global Parenteral Drugs Revenue by Region (2017-2022)
2.5.2 Global Parenteral Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Parenteral Drugs Sales by Manufacturers
3.1.1 Global Top Parenteral Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Parenteral Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Parenteral Drugs in 2021
3.2 Global Parenteral Drugs Revenue by Manufacturers
3.2.1 Global Parenteral Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Parenteral Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Parenteral Drugs Revenue in 2021
3.3 Global Parenteral Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Parenteral Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Parenteral Drugs Sales by Type
4.1.1 Global Parenteral Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Parenteral Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Parenteral Drugs Sales Market Share by Type (2017-2028)
4.2 Global Parenteral Drugs Revenue by Type
4.2.1 Global Parenteral Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Parenteral Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Parenteral Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Parenteral Drugs Price by Type
4.3.1 Global Parenteral Drugs Price by Type (2017-2022)
4.3.2 Global Parenteral Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Parenteral Drugs Sales by Application
5.1.1 Global Parenteral Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Parenteral Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Parenteral Drugs Sales Market Share by Application (2017-2028)
5.2 Global Parenteral Drugs Revenue by Application
5.2.1 Global Parenteral Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Parenteral Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Parenteral Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Parenteral Drugs Price by Application
5.3.1 Global Parenteral Drugs Price by Application (2017-2022)
5.3.2 Global Parenteral Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Parenteral Drugs Market Size by Type
6.1.1 North America Parenteral Drugs Sales by Type (2017-2028)
6.1.2 North America Parenteral Drugs Revenue by Type (2017-2028)
6.2 North America Parenteral Drugs Market Size by Application
6.2.1 North America Parenteral Drugs Sales by Application (2017-2028)
6.2.2 North America Parenteral Drugs Revenue by Application (2017-2028)
6.3 North America Parenteral Drugs Market Size by Country
6.3.1 North America Parenteral Drugs Sales by Country (2017-2028)
6.3.2 North America Parenteral Drugs Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
6.3.5 Mexico
7 Europe
7.1 Europe Parenteral Drugs Market Size by Type
7.1.1 Europe Parenteral Drugs Sales by Type (2017-2028)
7.1.2 Europe Parenteral Drugs Revenue by Type (2017-2028)
7.2 Europe Parenteral Drugs Market Size by Application
7.2.1 Europe Parenteral Drugs Sales by Application (2017-2028)
7.2.2 Europe Parenteral Drugs Revenue by Application (2017-2028)
7.3 Europe Parenteral Drugs Market Size by Country
7.3.1 Europe Parenteral Drugs Sales by Country (2017-2028)
7.3.2 Europe Parenteral Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Parenteral Drugs Market Size by Type
8.1.1 Asia Pacific Parenteral Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Parenteral Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Parenteral Drugs Market Size by Application
8.2.1 Asia Pacific Parenteral Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Parenteral Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Parenteral Drugs Market Size by Region
8.3.1 Asia Pacific Parenteral Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Parenteral Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Parenteral Drugs Market Size by Type
9.1.1 Latin America Parenteral Drugs Sales by Type (2017-2028)
9.1.2 Latin America Parenteral Drugs Revenue by Type (2017-2028)
9.2 Latin America Parenteral Drugs Market Size by Application
9.2.1 Latin America Parenteral Drugs Sales by Application (2017-2028)
9.2.2 Latin America Parenteral Drugs Revenue by Application (2017-2028)
9.3 Latin America Parenteral Drugs Market Size by Country
9.3.1 Latin America Parenteral Drugs Sales by Country (2017-2028)
9.3.2 Latin America Parenteral Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Parenteral Drugs Market Size by Type
10.1.1 Middle East and Africa Parenteral Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Parenteral Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Parenteral Drugs Market Size by Application
10.2.1 Middle East and Africa Parenteral Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Parenteral Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Parenteral Drugs Market Size by Country
10.3.1 Middle East and Africa Parenteral Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Parenteral Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Ostuka Pharmaceutical
11.1.1 Ostuka Pharmaceutical Corporation Information
11.1.2 Ostuka Pharmaceutical Overview
11.1.3 Ostuka Pharmaceutical Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Ostuka Pharmaceutical Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Ostuka Pharmaceutical Recent Developments
11.2 Teva Pharmaceutical Industries
11.2.1 Teva Pharmaceutical Industries Corporation Information
11.2.2 Teva Pharmaceutical Industries Overview
11.2.3 Teva Pharmaceutical Industries Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Teva Pharmaceutical Industries Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Pharmaceutical Industries Recent Developments
11.3 Kelun Pharma
11.3.1 Kelun Pharma Corporation Information
11.3.2 Kelun Pharma Overview
11.3.3 Kelun Pharma Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Kelun Pharma Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Kelun Pharma Recent Developments
11.4 Cook Pharmica
11.4.1 Cook Pharmica Corporation Information
11.4.2 Cook Pharmica Overview
11.4.3 Cook Pharmica Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Cook Pharmica Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cook Pharmica Recent Developments
11.5 Patheon
11.5.1 Patheon Corporation Information
11.5.2 Patheon Overview
11.5.3 Patheon Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Patheon Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Patheon Recent Developments
11.6 BAG Healthcare
11.6.1 BAG Healthcare Corporation Information
11.6.2 BAG Healthcare Overview
11.6.3 BAG Healthcare Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 BAG Healthcare Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 BAG Healthcare Recent Developments
11.7 Beximco Pharma
11.7.1 Beximco Pharma Corporation Information
11.7.2 Beximco Pharma Overview
11.7.3 Beximco Pharma Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Beximco Pharma Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Beximco Pharma Recent Developments
11.8 Baxter Healthcare Corporation
11.8.1 Baxter Healthcare Corporation Corporation Information
11.8.2 Baxter Healthcare Corporation Overview
11.8.3 Baxter Healthcare Corporation Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Baxter Healthcare Corporation Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Baxter Healthcare Corporation Recent Developments
11.9 B. Braun
11.9.1 B. Braun Corporation Information
11.9.2 B. Braun Overview
11.9.3 B. Braun Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 B. Braun Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 B. Braun Recent Developments
11.10 Fresenius
11.10.1 Fresenius Corporation Information
11.10.2 Fresenius Overview
11.10.3 Fresenius Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Fresenius Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Fresenius Recent Developments
11.11 Albert David
11.11.1 Albert David Corporation Information
11.11.2 Albert David Overview
11.11.3 Albert David Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Albert David Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Albert David Recent Developments
11.12 BML Parenteral Drugs
11.12.1 BML Parenteral Drugs Corporation Information
11.12.2 BML Parenteral Drugs Overview
11.12.3 BML Parenteral Drugs Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 BML Parenteral Drugs Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 BML Parenteral Drugs Recent Developments
11.13 Pfizer (Hospira)
11.13.1 Pfizer (Hospira) Corporation Information
11.13.2 Pfizer (Hospira) Overview
11.13.3 Pfizer (Hospira) Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Pfizer (Hospira) Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Pfizer (Hospira) Recent Developments
11.14 Pisa
11.14.1 Pisa Corporation Information
11.14.2 Pisa Overview
11.14.3 Pisa Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Pisa Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Pisa Recent Developments
11.15 Ozon Pharmaceuticals Ltd
11.15.1 Ozon Pharmaceuticals Ltd Corporation Information
11.15.2 Ozon Pharmaceuticals Ltd Overview
11.15.3 Ozon Pharmaceuticals Ltd Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Ozon Pharmaceuticals Ltd Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Ozon Pharmaceuticals Ltd Recent Developments
11.16 Aspen Holdings
11.16.1 Aspen Holdings Corporation Information
11.16.2 Aspen Holdings Overview
11.16.3 Aspen Holdings Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Aspen Holdings Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Aspen Holdings Recent Developments
11.17 PSI Ltd
11.17.1 PSI Ltd Corporation Information
11.17.2 PSI Ltd Overview
11.17.3 PSI Ltd Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 PSI Ltd Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 PSI Ltd Recent Developments
11.18 Wintac Limited
11.18.1 Wintac Limited Corporation Information
11.18.2 Wintac Limited Overview
11.18.3 Wintac Limited Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Wintac Limited Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Wintac Limited Recent Developments
11.19 AXA Parenterals Ltd
11.19.1 AXA Parenterals Ltd Corporation Information
11.19.2 AXA Parenterals Ltd Overview
11.19.3 AXA Parenterals Ltd Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 AXA Parenterals Ltd Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 AXA Parenterals Ltd Recent Developments
11.20 Acebright
11.20.1 Acebright Corporation Information
11.20.2 Acebright Overview
11.20.3 Acebright Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Acebright Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Acebright Recent Developments
11.21 Southwest Pharmaceutical
11.21.1 Southwest Pharmaceutical Corporation Information
11.21.2 Southwest Pharmaceutical Overview
11.21.3 Southwest Pharmaceutical Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Southwest Pharmaceutical Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Southwest Pharmaceutical Recent Developments
11.22 Abbott
11.22.1 Abbott Corporation Information
11.22.2 Abbott Overview
11.22.3 Abbott Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Abbott Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Abbott Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Parenteral Drugs Industry Chain Analysis
12.2 Parenteral Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Parenteral Drugs Production Mode & Process
12.4 Parenteral Drugs Sales and Marketing
12.4.1 Parenteral Drugs Sales Channels
12.4.2 Parenteral Drugs Distributors
12.5 Parenteral Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Parenteral Drugs Industry Trends
13.2 Parenteral Drugs Market Drivers
13.3 Parenteral Drugs Market Challenges
13.4 Parenteral Drugs Market Restraints
14 Key Findings in The Global Parenteral Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
